# Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma

> **NCT00855881** · PHASE2 · UNKNOWN · sponsor: **Mackay Memorial Hospital** · enrollment: 115 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** tegafur-uracil

## Key facts

- **NCT ID:** NCT00855881
- **Lead sponsor:** Mackay Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2014-12
- **Final completion:** 2016-12
- **Target enrollment:** 115 (ESTIMATED)
- **Last updated:** 2011-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00855881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00855881, "Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00855881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*